FDA issues revised prescribing info for Azilect

WASHINGTON The Food and Drug Administration has issued revised prescribing information for Azilect, a drug for treating Parkinson's disease, manufactured by Teva Pharmaceuticals. The revision allows patients to use the drug while taking various medications, including over-the-counter cough and cold remedies, and eliminates a dietary restriction on levels of tyramine, an amino acid found in air-dried meats, aged cheeses and many soy products. Because of increased sensitivity in some patients, however, the new labeling recommends against high levels of the acid.

The FDA first approved Azilect in 2006.